Medicine Recommendations

Type 2 diabetes mellitus

Suitable for initiation in primary care in line with restrictions (see background paragraph)

Depressive illness

Insomnia (short term use)

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Breathlessness

Breathlessness in the last days of life

Short term use in anxiety and insomnia

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Short term use in anxiety and insomnia

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Insomnia (short term use)

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Various indications

The colour classification is dependant on the indication. See LMWH Summary Prescribing Guide for more details. 

Schizophrenia or bipolar disorder (NICE TA286 - terminated appraisal)

NICE TA286 - Loxapine Inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)

Treatment of schizophrenia in adults aged 18 and over

For treating thrombocytopenia in people with chronic liver disease needing a planned invasive procedure (TA617)

Age Related Macular Degeneration

Constipation in adults

Constipation in children

Treatment & prevention of magnesium deficiency

Primary insomnia in those over 55

Sleep problems in patients with dementia associated with Alzheimer’s

Colonis liquid 1mg/ml and 3mg tablets for all indications, including insomnia and jet lag

For the Treatment of Rapid Eye Movement (REM) Sleep Behaviour Disorder (RBD) in Parkinson’s Disease and Lewy Body Dementia

Adults with learning disabilities

Sleep disturbance in adults with ADHD

Sleep disorders in the blind

Adults with complex neurodevelopmental disorders that the specialist considers eligible

Children with learning disabilities

Children with ADHD

Children and adolescents with Autism Spectrum Disorder (ASD) and / or Smith-Magenis syndrome

Cerebral palsy

Children with complex neurodevelopmental disorders that the specialist considers eligible

Alzheimer's Dementia (NICE TA217)

NICE TA217 - Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease

MHRA Drug Safety Update - Memantine pump device (Ebixa): risk of medication errors

Short term use in anxiety

The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.